Dexamethasone: all 1,888 studies that test it

Page 3 of 19. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.

• The Danish Out-of-Hospital Cardiac Arrest StudyRecruitingNCT05895838Phase 3
• Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple MyelomaRecruitingNCT05857982Phase 1/2
• TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia IIRecruitingNCT05848687Phase 1/2
• Antenatal Dexamethasone for Late Preterm DeliveriesRecruitingNCT05841121Phase 1
• The Effect of Intercostal Nerve Block With Dexamethasone and Ropivacaine on Rebound Pain After Thoracoscopic SurgeryNot yet recruitingNCT05825378Not applicable
• Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF)RecruitingNCT05809011Phase 2/3
• Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine for Intermediate Cervical Plexus BlockRecruitingNCT05793060Phase 4
• Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple MyelomaRecruitingNCT05789303Phase 2
• A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory ConditionRecruitingNCT05787574Phase 2
• HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05751044Phase 1/2
• HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05745714Phase 1/2
• A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingNCT05736419Phase 2
• The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and HypocalcaemiaRecruitingNCT05732883Phase 2
• Evaluating the Effect of Intravenous Dexamethasone on the Duration of Spinal Anesthesia After Cesarean DeliveryRecruitingNCT05731960Phase 4
• Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.RecruitingNCT05721027Phase 4
• The OPTIMISE StudyRecruitingNCT05716945Phase 4
• GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5RecruitingNCT05695508Phase 2
• Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)RecruitingNCT05681260Phase 3
• Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)RecruitingNCT05668455Phase 3
• HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05658640Phase 1/2
• Dexamethasone in the Prevention of Post-spinal Paralytic Ileus After Cesarean SectionRecruitingNCT05654649Phase 1/2
• A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaRecruitingNCT05651932Phase 1
• Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac SurgeryRecruitingNCT05635227Not applicable
• Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)RecruitingNCT05631405Not applicable
• A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple MyelomaRecruitingNCT05583617Phase 1/2
• A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide RefractoryNot yet recruitingNCT05581875Phase 1/2
• A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple MyelomaRecruitingNCT05573802Phase 1/2
• Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLHRecruitingNCT05546060Phase 1
• Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple MyelomaRecruitingNCT05530421Phase 2
• B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021RecruitingNCT05518383Phase 4
• Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALLRecruitingNCT05495035Phase 1
• Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic LymphohistiocytosisRecruitingNCT05491304Phase 4
• Preoperative Corticosteroids in Autoimmune Thyroid DiseaseRecruitingNCT05435547Phase 4
• Transversus Abdominis Plane Blocks With and Without DexamethasoneRecruitingNCT05432934Phase 1/2
• Selinexor Plus VRd in High Risk Newly Diagnosed Multiple MyelomaRecruitingNCT05422027Phase 1/2
• Dexamethasone in Traumatic Brain InjuryRecruitingNCT05323149Phase 3
• A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)RecruitingNCT05319730Phase 1/2
• A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome InhibitorNot yet recruitingNCT05298683Phase 2
• Spinal Fusions Steroid StudyEnrolling by invitationNCT05287035Early Phase 1
• A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant IneligibleRecruitingNCT05280275Phase 1/2
• Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM PatientsRecruitingNCT05272826Phase 2
• Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary PlasmacytomaRecruitingNCT05248633Phase 2
• Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk MyelomaRecruitingNCT05208307Phase 2
• Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin LymphomaRecruitingNCT05180097Phase 2
• Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple MyelomaRecruitingNCT05145400Phase 2
• Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhageRecruitingNCT05132920Phase 3
• Transforaminal Epidural Platelet Rich Plasma Versus Epidural Steroid Injection for Lumbosacral Radicular PainRecruitingNCT05129085Phase 4
• Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular OsteotomyRecruitingNCT05120076Phase 3
• ESP Block vs Control for Pain Control Following Percutaneous NephrolithotomyRecruitingNCT05024344Not applicable
• IgIV Plus Prednisone vs High-dose Dexamethasone for ITPRecruitingNCT04968899Phase 3
• Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.RecruitingNCT04915248Phase 2
• Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryRecruitingNCT04891289Phase 2
• Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple MyelomaRecruitingNCT04776395Phase 2
• Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in ChildrenRecruitingNCT04654507Phase 3
• Isatuximab in Combination With Novel Agents in RRMM - Master ProtocolRecruitingNCT04643002Phase 1/2
• First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)RecruitingNCT04638790Phase 3
• The PRIME Study: A Randomized, Controlled, Prospective StudyRecruitingNCT04549935Phase 4
• Anosmia and / or Ageusia and Early Corticosteroid UseRecruitingNCT04528329Phase 4
• Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaRecruitingNCT04508790Phase 2
• Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder ArthroplastyRecruitingNCT04507412Phase 4
• Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous LineageRecruitingNCT04440267Phase 2
• A Study to Compare Different Ways of Steroid Administration After Total Knee ImplantationRecruitingNCT04432012Phase 4
• Randomised Evaluation of COVID-19 TherapyRecruitingNCT04381936Phase 3
• Dextenza in the Post-op Management of Vitreoretinal SurgeriesRecruitingNCT04371445Phase 4
• Dexamethasone for Cerebral ToxoplasmosisRecruitingNCT04341155Phase 2
• Restrictive Use of Dexamethasone in GlioblastomaRecruitingNCT04266977Not applicable
• Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal InsufficiencyRecruitingNCT04240054Phase 2
• Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular EdemaRecruitingNCT04225611Phase 1/2
• Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer SurgeryRecruitingNCT04209218Not applicable
• A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract SurgeryRecruitingNCT04205916Phase 4
• Subjective Intraoperative Use of Epidural Steroid Administration Following DiscectomyRecruitingNCT04182997Phase 4
• International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic LymphomaRecruitingNCT04043494Phase 3
• Transforaminal Epidural Injection in Acute SciaticaRecruitingNCT03924791Not applicable
• Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaRecruitingNCT03719105Early Phase 1
• R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's MacroglobulinemiaRecruitingNCT03697356Phase 2
• VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple MyelomaRecruitingNCT03641456Phase 2
• Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of AnaphylaxisRecruitingNCT03523221Phase 1
• Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaRecruitingNCT03418038Phase 2
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaRecruitingNCT03136146Phase 2
• European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsRecruitingNCT02813135Phase 1/2
• The Letrozole Administration During Luteal PhaseNot yet recruitingNCT02686151Phase 3
• Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruitingNCT02416388Phase 2/3
• Dexamethasone Versus Prednisone in Heart Failure Patients, Hospitalized With Exacerbation of Chronic Obstructive Pulmonary Disease.RecruitingNCT02237820Phase 4
• Dexamethasone for Reduction of Post Thoracotomy Pain SyndromeRecruitingNCT02112864Not applicable
• Improving White Blood Cell Collection From Healthy DonorsRecruitingNCT01553214Phase 4
• Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMMActive, not recruitingNCT07150104Phase 1/2Results posted
• Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMMActive, not recruitingNCT07150091Phase 1/2Results posted
• Open-Label Extension of EryDex Study IEDAT-04-2022TerminatedNCT06664853Phase 3Results posted
• A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract SurgeryCompletedNCT06497699Phase 4Results posted
• Evaluate the Neurological Effects of EryDex on Subjects With A-TCompletedNCT06193200Phase 3Results posted
• Isa-Pom-Dex in Elderly/Frail Subjects With RRMMActive, not recruitingNCT05911321Phase 2Results posted
• Steroids in Occipital Nerve Block for Treatment of HeadacheCompletedNCT05732532Phase 4Results posted
• Dexamethasone vs Ondansetron After Cesarean DeliveryCompletedNCT05692245Phase 4Results posted
• Premedication to Reduce Amivantamab Associated Infusion Related ReactionsActive, not recruitingNCT05663866Phase 2Results posted
• DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under AnesthesiaCompletedNCT05620901Early Phase 1Results posted
• Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and VomitingTerminatedNCT05590923Phase 4Results posted
• Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell LymphomaTerminatedNCT05498220Phase 2Results posted
• Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL.CompletedNCT05372315Phase 4Results posted
• MIDCAB (Mid-Calf Block) for Foot SurgeryCompletedNCT05368012Phase 4Results posted
• MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple MyelomaTerminatedNCT05090566Phase 2Results posted

← Dexamethasone overview